Angiodynamics (ANGO) Research & Development (2010 - 2026)
Angiodynamics' (ANGO) quarterly Research & Development came in at $92.1 million in Q2 2026, up 1298.06% YoY from $6.6 million in Q2 2025, and up 1200.56% on a QoQ basis from $7.1 million in Q1 2026.
Angiodynamics (ANGO) Research & Development (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Research & Development data on file, last reported at $92.1 million in Q2 2026.
- Quarterly Research & Development rose 1298.06% year-over-year to $92.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $132.3 million (up 106.89% YoY) and the FY2026 annual result came in at $113.4 million, up 332.47% from the prior year.
- Research & Development rose to $92.1 million in Q2 2026, from $7.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $92.1 million in Q2 2026 to a low of -$10.5 million in Q2 2024.
- A 5-year average of $21.5 million and a median of $14.5 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development plunged 233.49% — and 2026, when it soared 1298.06%.
- Tracing ANGO's Research & Development over 5 years: stood at $6.8 million in 2022, then gained by 26.62% to $8.7 million in 2023, then surged by 195.55% to $25.6 million in 2024, then climbed by 4.38% to $26.7 million in 2025, then jumped by 244.92% to $92.1 million in 2026.
- The last three Research & Development figures came in at $92.1 million (Q2 2026), $7.1 million (Q1 2026), and $26.7 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | 31.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 92.13 Mn |
| Feb 28, 2026 | 7.08 Mn |
| Nov 30, 2025 | 26.71 Mn |
| Aug 31, 2025 | 6.42 Mn |
| May 31, 2025 | 6.59 Mn |
| Feb 28, 2025 | 25.50 Mn |
| Nov 30, 2024 | 25.59 Mn |
| Aug 31, 2024 | 6.29 Mn |
| May 31, 2024 | -10.49 Mn |
| Feb 29, 2024 | 25.41 Mn |
| Nov 30, 2023 | 8.66 Mn |
| Aug 31, 2023 | 7.94 Mn |
| May 31, 2023 | 7.86 Mn |
| Feb 28, 2023 | 25.41 Mn |
| Nov 30, 2022 | 6.84 Mn |
| Aug 31, 2022 | 26.54 Mn |
| May 31, 2022 | 72.43 Mn |
| Feb 28, 2022 | 20.42 Mn |
| Nov 30, 2021 | 8.20 Mn |
| Aug 31, 2021 | 24.45 Mn |